Stat: Cultural signals emerge in the age of rising GLP-1 use

GLP-1 adoption in the US is accelerating, with Morgan Stanley forecasting 19m users by 2026 and 55m by 2035 – equivalent to 15% of the population. Expanded access and oral formulations are expected to drive uptake beyond early adopters.